Systemic immunoglobulin light chain amyloidosis is a protein misfolding disease caused by
the conversion of immunoglobulin light chains from their soluble functional states into highly …

Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma
cell dyscrasia that consistently precedes multiple myeloma (MM) with a 1% risk of …

AL amyloidosis is a systemic amyloidosis and is associated with an underlying plasma cell
dyscrasia. High dose intravenous melphalan and autologous stem cell transplantation was …

Immunoglobulin light chain amyloidosis (AL) should be considered in any patient that
presents to a cancer care provider with nephrotic range proteinuria, heart failure with …

Immunoglobulin light chain amyloidosis (AL) commonly presents with nephrotic range
proteinuria, heart failure with preserved ejection fraction, nondiabetic peripheral neuropathy …

Monoclonal gammopathy of renal significance (MGRS) is a recognized clinical entity.
Literature regarding treatment and its outcomes in MGRS is sparse due to the rarity and …

Monoclonal Gammopathy of Undetermined Significance (MGUS) is considered to be a
benign precursor condition that may progress to a lymphoproliferative disease or multiple …

Monoclonal gammopathy of renal significance (MGRS) is a hemato-nephrological term
referring to a heterogeneous group of kidney disorders characterized by direct or indirect …

Simple Summary Monoclonal gammopathy of clinical significance (MGCS) is a recently
recognized clinical-pathological entity. Symptoms are caused by the presence of a …

AL amyloidosis is caused by the excessive production of nonfunctional immunoglobulins,
leading to the formation of amyloid fibrils that damage vital organs, especially the heart and …